Par Drugs And Chemicals Limited (PAR) - Total Liabilities

Latest as of September 2025: Rs210.91 Million INR ≈ $2.28 Million USD

Based on the latest financial reports, Par Drugs And Chemicals Limited (PAR) has total liabilities worth Rs210.91 Million INR (≈ $2.28 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PAR operating cash flow to assess how effectively this company generates cash.

Par Drugs And Chemicals Limited - Total Liabilities Trend (2016–2025)

This chart illustrates how Par Drugs And Chemicals Limited's total liabilities have evolved over time, based on quarterly financial data. Check PAR asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Par Drugs And Chemicals Limited Competitors by Total Liabilities

The table below lists competitors of Par Drugs And Chemicals Limited ranked by their total liabilities.

Company Country Total Liabilities
IDT Australia Ltd
AU:IDT
Australia AU$15.03 Million
General Environmental Conservation Public Company Limited
BK:GENCO
Thailand ฿177.49 Million
Lancartama Sejati Tbk
JK:TAMA
Indonesia Rp140.19 Billion
Sarytogan Graphite Ltd
AU:SGA
Australia AU$341.96K
Globe Textiles (India) Limited
NSE:GLOBE
India Rs2.77 Billion
Priceworth International Bhd
KLSE:7123
Malaysia RM149.37 Million
Green Hydrogen Systems AS
CO:GREENH
Denmark Dkr1.54 Billion
Rugby Mining Limited
V:RUG
Canada CA$1.38 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Par Drugs And Chemicals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Par Drugs And Chemicals Limited worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.57 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.20 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.17 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Par Drugs And Chemicals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Par Drugs And Chemicals Limited (2016–2025)

The table below shows the annual total liabilities of Par Drugs And Chemicals Limited from 2016 to 2025.

Year Total Liabilities Change
2025-03-31 Rs204.15 Million
≈ $2.21 Million
+27.76%
2024-03-31 Rs159.79 Million
≈ $1.73 Million
-9.36%
2023-03-31 Rs176.30 Million
≈ $1.91 Million
-6.29%
2022-03-31 Rs188.13 Million
≈ $2.03 Million
-22.16%
2021-03-31 Rs241.70 Million
≈ $2.61 Million
+23.94%
2020-03-31 Rs195.01 Million
≈ $2.11 Million
-12.31%
2019-03-31 Rs222.38 Million
≈ $2.40 Million
-33.10%
2018-03-31 Rs332.40 Million
≈ $3.59 Million
-9.77%
2017-03-31 Rs368.38 Million
≈ $3.98 Million
-9.43%
2016-03-31 Rs406.75 Million
≈ $4.40 Million
--

About Par Drugs And Chemicals Limited

NSE:PAR India Drug Manufacturers - Specialty & Generic
Market Cap
$12.09 Million
Rs1.12 Billion INR
Market Cap Rank
#26399 Global
#1478 in India
Share Price
Rs90.83
Change (1 day)
-0.66%
52-Week Range
Rs78.58 - Rs118.56
All Time High
Rs348.45
About

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, m… Read more